Resources & Information

Dec 2 2020

Changes to COVID-19 prescribing rules

Comments:   comments  Print Friendly Version  |   Share this item
In October, NCMB issued orders to remove the drugs Tamiflu (oseltamivir) and azithromycin from administrative rules that set restrictions on medications prescribed for the treatment of COVID-19.

Please note that the rules do not prohibit a treating provider from prescribing any medication he or she believes may benefit a patient with COVID-19, as long as that patient has been diagnosed with the illness. The rules do prohibit the prescribing of certain medications to patients who do not have presumed or confirmed COVID-19, but wish to have medicine on hand in case they become ill.

The remaining restricted medications are:

(1) Hydroxychloroquine;
(2) Chloroquine;
(3) Lopinavir-ritonavir;
(4) Ribavirin; and
(5) Darunavir

Read the order amending prescribing rules for physicians and PAs.

Read the order amending prescribing rules for nurse practitioner.

Read the amended prescribing rules.

 No Comments on this article

 Post a comment on this article
Please do not include links to external websites in your comment. Please limit comments to no more than 300 words. The NCMB reserves the right to edit comments to meet the length limit. Abusive or profane remarks and personal attacks will not be published. The editor will make every effort to review and post comments in a timely fashion.